Cargando…
Overexpressed Histocompatibility Minor 13 was Associated with Liver Hepatocellular Carcinoma Progression and Prognosis
Among primary liver carcinoma cases, the proportion of liver hepatocellular carcinoma (LIHC) cases is 75%–85%. Current treatments for LIHC include chemotherapy, surgical excision, and liver transplantation, which are effective for early LIHC treatment. Nevertheless, the early symptoms of liver carci...
Autores principales: | Zong, Rui-Qing, Zhang, Hong-Yan, Li, Xiao-Ying, Li, Yi-ran, Chen, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550386/ https://www.ncbi.nlm.nih.gov/pubmed/36262249 http://dx.doi.org/10.1155/2022/7067743 |
Ejemplares similares
-
Pan-cancer analysis suggests histocompatibility minor 13 is an unfavorable prognostic biomarker promoting cell proliferation, migration, and invasion in hepatocellular carcinoma
por: Liu, Jun, et al.
Publicado: (2022) -
Overexpression of microRNA let-7 correlates with disease progression and poor prognosis in hepatocellular carcinoma
por: Shi, Wenxia, et al.
Publicado: (2017) -
TRIP13 overexpression in hepatocellular carcinoma: implications for poor prognosis and immune cell infiltration
por: Xue, Jiapeng, et al.
Publicado: (2023) -
Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma
por: Wang, Wei, et al.
Publicado: (2023) -
CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma
por: Zheng, Hao, et al.
Publicado: (2017)